Picture of Smith & Nephew logo

SN. Smith & Nephew Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-8.38%
3m-13.89%
6m-8.57%
1yr-21.83%
Volume Change (%)
10d/3m+48.73%
Price vs... (%)
52w High-24.63%
50d MA-6.41%
200d MA-12.08%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.29
PEG Ratio (f)1
EPS Growth (f)18.11%
Dividend Yield (f)2.76%
Valuation (ttm)IndustryMarket
Price to Book Value2.12
Price to Tang. Book10.83
Price to Free Cashflow36.33
Price to Sales2.19
EV to EBITDA11.03

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.4%
Return on Equity9.29%
Operating Margin12.87%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m4,7654,9045,1384,5605,2125,271.225,502.892.22%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+28.83+1.96-2.78-23.66-4.22+22.92+15.56n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Smith & Nephew EPS forecast chart

Profile Summary

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Directors

Last Annual
December 31st, 2021
Last Interim
July 2nd, 2022
Incorporated
February 17th, 1937
Public Since
August 13th, 1951
No. of Shareholders
14,346
No. of Employees
18,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
872,505,009

SN. Share Price Performance

Latest News for SN.

Upcoming Events for SN.

Dividend For S1NN34.SA - 0.3004 BRL

Dividend For SN.L - 14.4000 USX

Dividend For SNN.N - 0.2880 USD

Q3 2022 Smith & Nephew PLC Trading Statement Release

Similar to SN.

Picture of Abingdon Health logo

Abingdon Health

gb flag iconLondon Stock Exchange

Picture of Advanced Medical Solutions logo

Advanced Medical Solutions

gb flag iconLondon Stock Exchange

Picture of Advanced Oncotherapy logo

Advanced Oncotherapy

gb flag iconLondon Stock Exchange

Picture of Angle logo

Angle

gb flag iconLondon Stock Exchange

Picture of Aptamer logo

Aptamer

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email